J Formos Med Assoc
-
We have demonstrated that bioresorbable vascular scaffold (BVS) for ACC/AHA type C lesions was associated with higher risks of long-term target lesion revascularization (TLR) and target lesion failure (TLF). We determined the specific time after which higher risks of BVS for type C lesions are reduced in a longer-term follow-up. ⋯ BVS provides a longer-term advantage, particularly for type C lesions with the majority requiring long stenting.